Rhythm Pharmaceuticals enters $855 million licensing agreement with LG Chem

Rhythm Pharmaceuticals has entered an $855 million licensing agreement with South Korea's LG Chem, according to an unconfirmed report.

Detected & updated continuously · Source: Nebula